According to GuruFocus list of three-year lows; Qunar Cayman Islands Ltd, CGG, Ladder Capital Corp. and Ultragenyx Pharmaceutical Inc. have all reached their three-year lows.
Qunar Cayman Islands Ltd. (QUNR, Financial) Reached the Three-Year Low of $21.25
The prices of Qunar Cayman Islands Ltd. (QUNR, Financial) shares have declined to close to the three-year low of $21.25, which is 42.4% off the three-year high of $36.73.
Qunar Cayman Islands Ltd. has a market cap of $2.42 billion; its shares were traded at around $21.25.
Quanar reported first quarter 2014 total revenue of $54 million and net loss per share of $0.03.
2 Gurus Initiated Positions: Frank Sands (Trades, Portfolio) bought 225,000 shares in the quarter that ended on 03/31/2014, which is 0.018% of the $38.38 billion portfolio of Sands Capital Management. Ron Baron (Trades, Portfolio) bought 211,147 shares in the quarter that ended on 12/31/2013, which is 0.023% of the $24.55 billion portfolio of Baron Funds. 1 Guru
2 Gurus Sold Out QUNR: Robert Karr (Trades, Portfolio) sold out his holdings in the quarter that ended on 03/31/2014. John Burbank (Trades, Portfolio) sold out his holdings in the quarter that ended on 03/31/2014.
CGG (CGG, Financial) Reached the Three-Year Low of $13.17
The prices of CGG (CGG, Financial) shares have declined to close to the three-year low of $13.17, which is 65.7% off the three-year high of $38.09.
CGG was established on July 23, 1931 to develop and market geophysical techniques for appraising underground geological resources. CGG has a market cap of $2.33 billion; its shares were traded at around $13.17 with and P/S ratio of 0.60. CGG had an annual average earnings growth of 2.30% over the past 10 years.
CGG has announced its first quarter 2014 results. Revenues were $806 million compared to $871 million a year ago. First quarter EBITDA decreased to $188 million from $272 million a year ago. Operating income was $35 million compared to $117 million last year.
Ladder Capital Corp (LADR, Financial) Reached the Three-Year Low of $17.11
The prices of Ladder Capital Corp (LADR, Financial) shares have declined to close to the 3-year low of $17.11, which is 16.5% off the three-year high of $19.77.
Ladder Capital Corp has a market cap of $1.7 billion; its shares were traded at around $17.11 with a P/E ratio of 41.90 and P/S ratio of 3.20.
The company has recently released its first quarter 2014 results ended March 31, 2014. Core earnings were $57.2 million compared to $94.4 million a year ago. Core EPS were $0.37, and the company has total equity of $1.43 billion, an increase of $245.6 million over the prior quarter.
Ultragenyx Pharmaceutical Inc. (RARE, Financial) Reached the Three-Year Low of $33.63
The prices of Ultragenyx Pharmaceutical Inc (RARE, Financial) shares have declined to close to the three-year low of $33.63, which is 53.2% off the three-year high of $69.77.
Ultragenyx Pharmaceutical Inc. has a market cap of $1.01 billion; its shares were traded at around $33.63.
Ultragenyx reported first quarter 2014 net loss of $18.4 million ($0.85 per diluted share) compared with a net loss of $8.2 million ($2.84 per share) a year ago.
Go here for the complete list of three-year lows.
